Taken together, our findings systematically confirmed that FOXP3 could inhibit breast cancer metastasis by regulating MTA1 expression, providing an experimental basis and new ideas for the treatment of metastatic breast cancer. The gene discussed is MTA1; the disease is breast carcinoma.